GeneDx Holdings annual return on equity
2021
2022
2023
2024
2025
GeneDx Holdings Return on Equity (ROE) Growth & History (WGS)
GeneDx Holdings's return on equity was −7.60% for fiscal 2025.
View full GeneDx Holdings company overviewGeneDx Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −7.60% | +14.50 pp |
| 2024 | 2024-12-31 | −22.10% | +50.88 pp |
| 2023 | 2023-12-31 | −72.97% | +98.10 pp |
| 2022 | 2022-12-31 | −171.07% | +674.34 pp |
| 2021 | 2021-12-31 | −845.41% | — |
GeneDx Holdings quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −7.12% | −11.16 pp |
| Q1 2026 | 2026-03-31 | −22.52% | −19.92 pp |
| Q4 2025 | 2025-12-31 | −5.88% | −8.30 pp |
| Q3 2025 | 2025-09-30 | −2.68% | +1.49 pp |
| Q2 2025 | 2025-06-30 | 4.04% | +18.58 pp |
| Q1 2025 | 2025-03-31 | −2.60% | +6.70 pp |
| Q4 2024 | 2024-12-31 | 2.42% | +13.11 pp |
| Q3 2024 | 2024-09-30 | −4.17% | +11.20 pp |
| Q2 2024 | 2024-06-30 | −14.54% | +0.42 pp |
| Q1 2024 | 2024-03-31 | −9.30% | +11.65 pp |
| Q4 2023 | 2023-12-31 | −10.69% | +65.08 pp |
| Q3 2023 | 2023-09-30 | −15.37% | −2.42 pp |
| Q2 2023 | 2023-06-30 | −14.96% | +2.78 pp |
| Q1 2023 | 2023-03-31 | −20.95% | +0.48 pp |
| Q4 2022 | 2022-12-31 | −75.77% | −65.45 pp |
| Q3 2022 | 2022-09-30 | −12.95% | — |
| Q2 2022 | 2022-06-30 | −17.74% | — |
| Q1 2022 | 2022-03-31 | −21.43% | — |
| Q4 2021 | 2021-12-31 | −10.32% | — |
GeneDx Holdings return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, GeneDx Holdings's return on equity increased from −845.41% to −7.60%, a change of +837.82 percentage points. The latest reported quarter, Q2 2026, shows −7.12%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings source filings ↗